Genus Pharmaceuticals

Park View House, 65 London Road, Newbury, Berkshire, RG14 1JN
Telephone: +44 (0)1635 568 400
Fax: +44 (0)1635 568 401
Medical Information Direct Line: +44 (0)870 851 0207
Medical Information e-mail: genus@medinformation.co.uk
Customer Care direct line: +44 (0)1635 568 445
Medical Information Fax: +44 (0)1793 710 387

Summary of Product Characteristics last updated on the eMC: 04/09/2009
SPC Anacal Rectal Ointment

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/09/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
Date of revision of text on the SPC:   18-Mar-2009
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

In section 9, the date of the latest renewal has been added.
Updated on 21/05/2008 and displayed until 04/09/2009
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   16-Apr-2008
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



Marketing Authorisation Holder
Genus Pharmaceuticals Limited,

Park View House

65 London Road,

Newbury,

Berkshire,

RG14 1JN, UK

Updated on 28/09/2006 and displayed until 21/05/2008
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   02/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Change to section 7 to Genus Pharmaceuticals
Change to section 8 Marketing Authorisation Number
Change to section 9  - February 2006
Change to section 10 - February 2006
Updated on 19/09/2003 and displayed until 28/09/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 24/08/2001 and displayed until 19/09/2003
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 27/06/2001 and displayed until 24/08/2001
Reasons for adding or updating:
  • Change to separate SPCs covering individual presentations

Active Ingredients/Generics

 
   heparinoid
   lauromacrogol-400